Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Repligen Corp shares valued at $3,271,688 were sold by Hunt Anthony on May 15 ’25. At $123.71 per share, Hunt Anthony sold 26,447 shares. The insider’s holdings dropped to 109,854 shares worth approximately $13.63 million following the completion of this transaction.
Also, Hunt Anthony purchased 26,447 shares, netting a total of over 3,394,208 in proceeds.
Before that, Hunt Anthony had sold 26,756 shares from its account. In a trade valued at $4,080,663, the Director traded Repligen Corp shares for $152.51 each. Upon closing the transaction, the insider’s holdings decreased to 26,756 shares, worth approximately $16.91 million.
As published in their initiating research note from Barclays on June 24, 2025, Repligen Corp [RGEN] has been an Overweight and the price target has been revised to $150. Analysts at Wolfe Research upgraded the stock from ‘”a Peer perform”‘ to ‘”an Outperform”‘ outlook in a report released in late April. As of March 18, 2025, Evercore ISI has initiated its “an In-line” rating for RGEN. Earlier on February 10, 2025, TD Cowen initiated its rating. Their recommendation was “a Buy” for RGEN stock.
Analyzing RGEN Stock Performance
On last trading session,, Repligen Corp [NASDAQ: RGEN] rose 3.58% to $124.04. The stock’s lowest price that day was $121.02, but it reached a high of $125.0 in the same session. During the last five days, there has been a drop of approximately -7.43%. Over the course of the year, Repligen Corp shares have jumped approximately 1.17%.
Support And Resistance Levels for Repligen Corp (RGEN)
RSI (Relative Strength Index) is 48.37 on the 14-day chart, showing neutral technical sentiment.
Is Repligen Corp subject to short interest?
Stocks of Repligen Corp saw a sharp steep in short interest on 2025-06-13 dropping by 7853.0 shares to 3.39 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.4 million shares. A decline of -0.23% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.73 of the overall float, the days-to-cover ratio (short ratio) decline to 4.73.
Which companies own the most shares of Repligen Corp (RGEN)?
In terms of Repligen Corp share price expectations, FactSet research, analysts set an average price target of 200 in the next 12 months, up nearly 67.01% from the previous closing price of $119.75. Analysts anticipate Repligen Corp stock to reach 220 by 2025, with the lowest price target being 155. In spite of this, 9 analysts ranked Repligen Corp stock as Buy at the end of 2025. On December 17, 2024, Canaccord Genuity assigned a price target of “a Hold” to the stock and initiated coverage with a $165.
